Number abstinent at completion of dose taper − Outpatient · Adults or adolescents with opioid dependence
It is very uncertain whether rapid changes number abstinent at completion of dose taper − Outpatient compared with slow taper of buprenorphine dose (very low certainty).
1 finding from 1 review
Completion of withdrawal treatment − Inpatient · Adults or adolescents with opioid dependence
Rapid showed no clear difference in completion of withdrawal treatment − Inpatient compared with slow taper of buprenorphine dose (low certainty).
1 finding from 1 review
Dysarthria intervention versus any control for stroke subgroup: persisting effects, activity level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
2 findings from 1 review
Dysarthria intervention versus any control: persisting effects, impairment level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Participation · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Dysarthria intervention versus any control: immediate effects, activity level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Dysarthria intervention versus any control: immediate effects, impairment level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Incisional hernia · patients undergoing a laparotomy incision
Fast absorbable showed no clear difference in incisional hernia compared with slow absorbable sutures (moderate certainty).
1 finding from 1 review
Wound infection · patients undergoing a laparotomy incision
Fast absorbable showed no clear difference in wound infection at last compared with slow absorbable sutures (moderate certainty).
1 finding from 1 review
Wound dehiscence · patients undergoing a laparotomy incision
Fast absorbable showed no clear difference in wound dehiscence at last compared with slow absorbable sutures (moderate certainty).
1 finding from 1 review
Sinus or fistula formation at last · patients undergoing a laparotomy incision
It is very uncertain whether fast absorbable changes sinus or fistula formation at last compared with slow absorbable sutures (very low certainty).
1 finding from 1 review
PE at 3 months · people aged ≥ 18 years with a diagnosis of new or recurrent VTE
Subcutaneous unfractionated heparin showed no clear difference in PE at 3 months compared with low molecular weight heparin (low certainty).
1 finding from 1 review
VTE‐related mortality4 · people aged ≥ 18 years with a diagnosis of new or recurrent VTE
Subcutaneous unfractionated heparin showed no clear difference in VTE‐related mortality at 3 months compared with low molecular weight heparin (low certainty).
1 finding from 1 review
Major bleedingd (3 months) · people aged ≥ 18 years with a diagnosis of new or recurrent VTE
Subcutaneous unfractionated heparin showed no clear difference in major bleedingd (3 months) compared with low molecular weight heparin (low certainty).
1 finding from 1 review
All‐cause mortality (7 days ‐ 3 months) · people aged ≥ 18 years with a diagnosis of new or recurrent VTE
Subcutaneous unfractionated heparin showed no clear difference in all‐cause mortality (7 days ‐ 3 months) compared with low molecular weight heparin (low certainty).
1 finding from 1 review
Asymptomatic VTE at 3 months · people aged ≥ 18 years with a diagnosis of new or recurrent VTE
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptomatic recurrent VTE at 3 months · people aged ≥ 18 years with a diagnosis of new or recurrent VTE
Subcutaneous unfractionated heparin showed no clear difference in symptomatic recurrent VTE at 3 months compared with low molecular weight heparin (low certainty).
1 finding from 1 review
Symptomatic recurrent DVT at 3 months · people aged ≥ 18 years with a diagnosis of new or recurrent VTE
Subcutaneous unfractionated heparin showed no clear difference in symptomatic recurrent DVT at 3 months compared with low molecular weight heparin (low certainty).
1 finding from 1 review
Symptomatic improvement · adults with dry eye syndrome
The review found no eligible studies for this question.
1 finding from 1 review
Ocular surface staining · adults with dry eye syndrome
The review found no eligible studies for this question.
1 finding from 1 review